high triglycerides and glp 1 Potential of Glucagon-Like Peptide as a Regulator of Impaired Cholesterol Metabolism in the Brain The Role of GLP-1RA Medications

By producing sustained weight reduction and favorable changes in lipids, blood pressure, systemic inflammation, and endothelial biology, tirzepatide targets the central pathophysiological drivers of obesity-related HFpEF

Existing and old CNS drugs in the market has many side effects and associated with weight gains in patients

Although the weight loss effect seen with some of these GLP-1R agonists was thought to be related to slowed gastric emptying, the long-acting agents seem to result in greater weight reduction than the short-acting ones, suggesting certain other mechanism is dominant

Youll still need to adopt healthier habitslike eating smarter, moving more, and staying consistent

doi: 10.1111/ane.12793

At 8 weeks, adults lost a mean 1.1% of their body weight